• Michael Thorpy, Mariana Figuera-Losada, Imran Ahmed, Renee Monderer, Monica Petrisko, Chris Martin, Jamal Akhtar, Jacqueline Thorpy, and Carver Haines.
• Sleep-Wake Disorders Center, Montefiore Medical Center and Albert Einstein College of Medicine, New York, USA. Electronic address: michael.thorpy@einsteinmed.org.
• Sleep Med. 2020 Oct 1; 74: 86-90.

BackgroundWith the onset of the COVID-19 outbreak there has been concern that patients with obstructive sleep apnea (OSA) who develop COVID-19 may be at risk of greater morbidity and mortality than patients without OSA. COVID-19 is associated with an increased mortality in the elderly and particularly those with obesity, hypertension and diabetes, features which are typically seen in patients with OSA. This article describes the COVID-19 environment in New York City in which patients were evaluated and treated for OSA.MethodsA telephone questionnaire survey of 112 OSA patients determined the occurrence of COVID-19 in the sleep apnea population and the patients' perspective on sleep apnea Positive Airway Pressure (PAP) management during the COVID-19 outbreak. The three main objectives of the survey were as follows: (1) To discover how patients were coping with COVID-19 pandemic in terms of their sleep apnea and PAP use, (2) To determine whether PAP usage changed after the onset of the outbreak in terms of adherence, and (3) To find out if patients were concerned about whether they were at greater risk of contracting COVID-19 because of their sleep apnea and, if they became infected, whether COVID-19 might result in greater complications because of the presence of sleep apnea.Results/ConclusionsThe adjustment in clinical management of OSA patients is described both during the peak of the outbreak in New York State (NYS), as well as the proposed modifications that will be instituted in order to return to full sleep center activities.Copyright © 2020 Elsevier B.V. All rights reserved.

36 keywords...

hide…